UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6K
REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 AND 15d -16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 1998
NATIONAL HEALTHCARE MANUFACTURING CORPORATION
(Name of Registrant)
251 Saulteaux Crescent, Winnipeg, Manitoba Canada R3J 3C7
(Address of principal executive offices)
1. News Release April 15, 1998
2. Material Change Report April 23, 1998
Indicate by check mark whether the Registrant files of will file annual
reports under cover of Form 20-F of Form 40-F.
Form 20-F X Form 40-F ___
Indicate by check mark whether the Registrant by furnishing the information
contained in this form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934. Yes ___ No _X
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1943 , the
registrant has duly cause this Form 6-K to be signed on its behalf by the
undersigned, thereunto duly authorized.
National Healthcare Manufacturing Corporation -- SEC No. 0-27998
(Registrant)
Date: April 23, 1998 By:/s/ M. Seyed Torabian
M. Seyed Torabian,
Vice President/Director
<PAGE>
National Healthcare Manufacturing Corp.
(NASDAQ:NHMCF / VSE:NHM)
Internet:www.nationalhealthcare.com
Contact: Alex P. Tsakumis
FOR IMMEDIATE RELEASE (800)883-8841 / (604)689-8581
NATIONAL HEALTHCARE MANUFACTURING CORP.
ACQUIRES BUDVA INTERNATIONAL L.L.C.
April 15, 1998 - National Healthcare Manufacturing Corporation (NHMC) is
pleased to announce that it has acquired 100% of privately held Budva
International L.L.C. (Budva) of Lenexa, Kansas. The Company has paid
US$1.085 million by the assumption of bank debt and outstanding loans,
plus three times the net annualized earnings which are to be paid in
NHMC's Class A common shares issued at the average closing price for the
five trading days preceding the 12 months from the closing date. Completion
of this acquisition is subject to regulatory approvals.
For the past six years Budva has been a leading manufacturer and provider
of disposable plastic products to the healthcare industry. Along with the
existing product offering of specimen collection containers, medicine and
denture cups and specialty products including sterile OR specimen
collections and sterile mid-stream collection kits, NHMC will expand the
existing 26 product lines to offer other plastic products for all three
major areas of healthcare. The Company intends to move all 13 injection
molding presses of this operation to its Antioch facility, located
outside of Chicago, to complement its existing plastic fusion molding
operations.
Mac Shahsavar, President & CEO stated, This vertical acquisition enables
NHMC to fully manufacture the majority of the products it uses within its
primary business of kits & trays manufacturing. The addition of the plastic
manufacturing combined with our existing capabilities to manufacture
solution and cellulose based paper products places NHMC in a very unique
position to control its overall costs and profitability. In addition,
Budva's existing sales and marketing network within the acute care,
physician offices and alternate healthcare including home healthcare and
nursing homes will create an opportunity for exposure of NHMC's entire
product line.
NHMC owns and operates the worlds first and only automated robotic
production facility capable of assembling and packaging various kits and
trays for medical and surgical procedures. Use of this proprietary
technology enables NHMC to produce these medical devices efficiently, cost
effectively, quickly and accurately thus providing an edge over its
competition who currently use manual labour. Through its wholly owned
subsidiaries, NHMC manufactures and distributes personal care and anti-
microbial products to health care and home care institutions. NHMC also
through its United States subsidiary, National Healthcare Logistics,
provides state of the art supply chain management to integrated hospital
systems.
On Behalf of the Board,
/s/M. Seyed Torabian
M. Seyed Torabian, P.Eng.
Executive Vice President
Neither NASDAQ nor the VSE have reviewed or accept responsibility for the
accuracy of this release.
<PAGE>
April 23, 1998
B.C. Securities Commission
1100 - 865 Hornby Street
Vancouver, B.C.
V7Z 2H4
ATTN: Statutory Filing
RE: Material Change Report
Dear Sir/Madam,
Following please find National Healthcare Manufacturing Corporation's
Material Change Report/Form 27 dated April 23, 1998.
Should you have any questions or need more information, please contact me
at (604) 689-8581.
Sincerely,
/s/Seyed Torabian
Seyed Torabian, P.Eng.
Executive Vice-President
copy:VSE Listings Dept.
Manitoba Securities Commission
U.S. Securities & Exchange Commission
NASDAQ
Standard & Poor's
Maitland & Company
<PAGE>
FORM 27
SECURITIES ACT (BRITISH COLUMBIA)
MATERIAL CHANGE REPORT UNDER SECTION 67 (1) (B) OF THE ACT
Item 1. Reporting Issuer
National Healthcare Manufacturing Corporation
251 Saulteaux Crescent
Winnipeg, Manitoba
R3J 3C7
Item 2. Date of Material Change
April 15, 1998
Item 3. Press Release
News release and notice of dissemination were issued to the
Vancouver Stock Exchange on April 15, 1998 and disseminated via
Canadian Corporate News, Market News Publishing and Vancouver
Stockwatch.
Item 4. Summary of Material Change
The Issuer announces that it has acquired 100% of privately held
Budva International L.L.C. of Lenexa, Kansas.
Item 5. Full Description of Material Change
Please refer to the attached News Release of the Issuer dated
April 15, 1998.
Item 6. Reliance in Section 67(2) of the Act
If the report is being filed on a confidential basis in reliance
on Section 67(2) of the Act, state the reason for such reliance.
N/A
Item 7. Omitted Information
N/A
<PAGE>
Item 8. Senior Officer
M. Seyed Torabian, the Executive Vice-President and Director of
the Issuer, is knowledgeable about the material change and this
report and may be contacted at (604) 689 - 8581 for further
information.
Item 9. Statement of Senior Officer
The foregoing accurately discloses the material change referred
to herein.
Dated at Vancouver, British Columbia, this 23rd day of April, 1998.
National Healthcare Manufacturing Corporation
Per: /s/Seyed Torabian
Seyed Torabian, P.Eng.
Executive Vice-President/Director
<PAGE>
National Healthcare Manufacturing Corp.
(NASDAQ:NHMCF / VSE:NHM)
Internet:www.nationalhealthcare.com
Contact: Alex P. Tsakumis
FOR IMMEDIATE RELEASE (800)883-8841 / (604)689-8581
NATIONAL HEALTHCARE MANUFACTURING CORP.
ACQUIRES BUDVA INTERNATIONAL L.L.C.
April 15, 1998 - National Healthcare Manufacturing Corporation (NHMC) is
pleased to announce that it has acquired 100% of privately held Budva
International L.L.C. (Budva) of Lenexa, Kansas. The Company has paid
US$1.085 million by the assumption of bank debt and outstanding loans,
plus three times the net annualized earnings which are to be paid in
NHMC's Class A common shares issued at the average closing price for the
five trading days preceding the 12 months from the closing date. Completion
of this acquisition is subject to regulatory approvals.
For the past six years Budva has been a leading manufacturer and provider
of disposable plastic products to the healthcare industry. Along with the
existing product offering of specimen collection containers, medicine and
denture cups and specialty products including sterile OR specimen
collections and sterile mid-stream collection kits, NHMC will expand the
existing 26 product lines to offer other plastic products for all three
major areas of healthcare. The Company intends to move all 13 injection
molding presses of this operation to its Antioch facility, located
outside of Chicago, to complement its existing plastic fusion molding
operations.
Mac Shahsavar, President & CEO stated, This vertical acquisition enables
NHMC to fully manufacture the majority of the products it uses within its
primary business of kits & trays manufacturing. The addition of the plastic
manufacturing combined with our existing capabilities to manufacture
solution and cellulose based paper products places NHMC in a very unique
position to control its overall costs and profitability. In addition,
Budva's existing sales and marketing network within the acute care,
physician offices and alternate healthcare including home healthcare and
nursing homes will create an opportunity for exposure of NHMC's entire
product line.
NHMC owns and operates the worlds first and only automated robotic
production facility capable of assembling and packaging various kits and
trays for medical and surgical procedures. Use of this proprietary
technology enables NHMC to produce these medical devices efficiently, cost
effectively, quickly and accurately thus providing an edge over its
competition who currently use manual labour. Through its wholly owned
subsidiaries, NHMC manufactures and distributes personal care and anti-
microbial products to health care and home care institutions. NHMC also
through its United States subsidiary, National Healthcare Logistics,
provides state of the art supply chain management to integrated hospital
systems.
On Behalf of the Board,
/s/Seyed Torabian
M. Seyed Torabian, P.Eng.
Executive Vice President
Neither NASDAQ nor the VSE have reviewed or accept responsibility for the
accuracy of this release.
